Last updated: July 17, 2026

Application No. 18/580,710

EARLY DETECTION OF INNATE IMMUNE DYSFUNCTION AND TREATMENT OF CONDITIONS ASSOCIATED THEREWITH

Non-Final OA

Filed

Jan 19, 2024

Priority

Jul 19, 2021 — provisional 63/223,353 +1 more

Examiner

MACFARLANE, STACEY NEE

Art Unit

1645

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

University of Florida Research Foundation Inc.

OA Round

1 (Non-Final)

This examiner grants 53% of cases after interview

— +39.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 826 resolved cases, 2023–2026

Examiner Intelligence

MACFARLANE, STACEY NEE View full profile →

Grants 53% of resolved cases

Career Allowance Rate

440 granted / 826 resolved

-6.7% vs TC avg

Strong +39% interview lift

Without

With

+39.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

46 currently pending

Career history

873

Total Applications

across all art units

Statute-Specific Performance

§101

3.6%

-36.4% vs TC avg

§103

38.8%

-1.2% vs TC avg

§102

16.2%

-23.8% vs TC avg

§112

20.2%

-19.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 826 resolved cases

Prosecution Timeline

Jan 19, 2024

Application Filed

May 29, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/812,678

Patent 12644154

Determining WT-1-Specific T Cells and WT-1 Specific T Cell Receptors (TCRS)

3y 10m to grant Granted Jun 02, 2026

18/637,770

Patent 12601749

BIOMARKER DETECTION PROCESS AND ASSAY OF NEUROLOGICAL CONDITION

1y 12m to grant Granted Apr 14, 2026

17/427,698

Patent 12594320

METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS

4y 8m to grant Granted Apr 07, 2026

17/616,031

Patent 12594330

ANTI-OPIOID COMPOUNDS AND METHODS OF MAKING AND USING SAME

4y 4m to grant Granted Apr 07, 2026

16/972,015

Patent 12590963

ANTI-CANCER TREATMENT OF PRESELECTED SUBJECTS AND SCREENING METHODS TO IDENTIFY SUSCEPTIBLE SUBJECTS

5y 3m to grant Granted Mar 31, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

53%

Grant Probability

93%

With Interview (+39.3%)

3y 4m (~10m remaining)

Median Time to Grant

Low

PTA Risk

Based on 826 resolved cases by this examiner. Grant probability derived from career allowance rate.